e-Participation for Guideline on Bioanalytical Method Validation and Study Sample Analysis
As part of Drug Safety Center’s commitment to ensuring that regulatory processes are transparent and inclusive. DSC announces the launch of a public consultation on the document titled Guideline on Public Consultation for Drug Safety Center (Guideline on Bioanalytical Method Validation and Study Sample Analysis) through e-Health Portal. This consultations aims to gather the opinions and feedback of the public regarding the guideline in order to ensure the clarity and comprehensiveness of its content.
-
To collect opinions and feedback from stakeholders.
-
To ensure the comprehensiveness of the guideline.
-
To enhance transparency and accountability in policy development.
-
To strengthen trust between the regulatory authority and the public.
-
To ensure alignment with international best practices
Drug Safety Center invites all citizens, residents, and stakeholders in the health sector to submit their comments and suggestions regarding the guideline by 11th of March, 2026 - 11th April, 2026.